The Massachusetts Pharmacists Association invites you to join us at the Massachusetts Pharmacists Summit. The Summit will take place at the Mass Mutual Center on November 14-15, 2019.
A block of rooms has been reserved at the MGM Hotel & Casino located directly across the street from the Convention Center for Thursday, November 14. A special room rate for attendees is available on Thursday, November of $159, plus applicable taxes (13.45%) and resort fees ($20 per day). Space is limited - Reserve your room at MGM now! Please note: if you wish to book a room on Wednesday or Friday evenings, contact the hotel directly at (413) 273-5000 to secure the dates outside of the block at the hotel's prevailing rate. Room block deadline: October 14, 2019

Preliminary Program

Thursday, November 14, 2019
1:00 - 5:30 PM Business Management Track (Independent Pharmacy Owner and Manager Track)  
  CPSEN Update  
  Employment Law for Business Owners (Not for CE)  
  Tax Strategies for Business Owners (Not for CE)  
  MA Legislative Update   
1:00 - 5:15 PM Health & Disease State Track  
 1:00 - 2:00 PM

Driven by Data: Cruising Down the Diabetes Highway
Kam L. Capoccia, PharmD, BCPS, CDE, RPh

  • Analyze the most recent data related to drug therapy in the management of diabetes
  • Apply the data to treat patients with Type 1 or Type 2 diabetes
  • Develop a patient centered diabetes treatment plan
 
 2:00 - 3:00 PM

Anticoagulation Management
Deana Hann, PharmD, RPh

  • Describe how clotting occurs and the morbidity associated with clots
  • Explain the clotting cascade and how pharmacotherapy targets this process
  • Summarize basic pathophysiology and appropriate treatment options for patients requiring anticoagulation treatment
  • Identify advantages and disadvantages of Direct Oral Anticoagulants (DOACs)
  • Identify how a pharmacist resolves medication related problems for patients on anticoagulation therapy
 
 3:15 - 4:15 PM

Clearing the Air about Vaping
Courtney Doyle Campbell, PharmD, RPh, AHSCP-CHC

  • Describe the evidence for Electronic Nicotine Delivery Devices (ENDS) use in smoking cessation
  • Review the health concerns associated with ENDS use
  • Explain the impact of ENDS use on the adolescent population
 
 4:15 - 5:15 PM

Immunization Update 2019
Todd Brown, MHP, RPh

  • Identify changes to the 2019 CDC Immunization Schedule
  • Explain changes to commercially available vaccines
  • Describe research and recommendations to increase vaccination rates
  • List important considerations associated with vaccination administration

 

 
5:00 - 6:30 PM Poster Session Judging  
5:30 PM Welcome Reception/Cocktail Hour - All Registered Attendees & Exhibitors Invited   
6:30 PM Awards & Installation Banquet 
*separate ticket required
 
Friday, November 15, 2019
6:45 - 7:45 AM

Breakfast - Exhibits Open

 
8:00 - 9:00 AM

Cannabinoids in Toxicology
Dayne Laskey, PharmD, RPh, DABAT

  • Describe different types of cannabinoids
  • Summarize recent trends in cannabinoid toxicity
  • Give examples of challenges in treating patients effected by cannabinoids
 
9:00 - 10:00 AM Keynote Speaker: The Opioid Epidemic: How We Got Here, How We Can End It
Michael Botticelli, M.Ed., B.A., Boston Medical Center, Grayken Center for Addiction Treatment
 
10:00-10:30 AM Coffee Break in Exhibit Hall  
10:30 -11:30 AM Panel: Survivors Guide to Pharmacy!  
11:30 AM-12:30 PM   Effective Grassroots Involvement in the Policy-making Process (Law)

Heidi Eckler, National Association of Chain Drug Stores

  • Describe the policy making process including how a bill becomes a law
  • Explain ways to meaningfully communicate with policy makers
  • Give examples of the power of grassroots involvement in the pharmacy industry
 
12:30 - 1:30 PM

Lunch Break

 

1:35 - 2:35 PM

Select One Session

Concurrent Session 1a: E-Prescribing Regulations (Law)
Lauren B. Nelson, Esq., Department of Public Health

 

Concurrent Session 1b: Non-Sterile Compounding 
Timothy Fensky, RPh, DPh, FACA

 

2:35 - 3:35 PM   

 

Select One Session

 


2:35 - 4:35 PM     

Concurrent Session 2a: An Old idea Gets New Attention - Evolving Role of Pharmacists in End of Life Care     
Alifia Waliji-Banglawala, PharmD, RPh

  • Summarize and Identify the role of the pharmacist in hospice and palliative care
  •  Assess, recommend, and treat symptoms commonly encountered in the hospice setting
  • Illustrate the hospice payment model and how it applies to providing medications in this patient population
  • Interpret the concept of death with dignity and how the pharmacist contributes to the care of patients (with their caregivers) for optimal outcomes

Concurrent Session 2b: Non-Sterile Compounding for Pharmacists and Pharmacy Technicians
Omar Allibhai, PharmD, RPh, FACA

  • Describe the changes between current and proposed USP <795>
  • Determine the assigned BUD of a non-sterile preparation
  • Breakdown the individual components need for a master formulation record
  • Determine appropriate quality control procedures for completed non-sterile preparation
 

 3:45 - 4:45 PM

 

Concurrent Session 3a: Long-Acting Injectables Administration*
Charlie Caley, PharmD, RPh

 

 
* This 1-hr CE does not meet the requirements outlined in DCP 19-2-105 Pharmacist Administration of Medications for the treatment of Mental Illness and Substance Use Disorder. Additional training is required.

Requirements for Credit

  • Program attendees can earn Continuing Pharmacy Education credits for this program by electronically logging onto the website: http://www.rxce.neu.edu, inserting the activity specific code number and successfully completing the activity learning assessment/evaluation form. Participant names will be checked against program attendance sheets for verification of attendance. 
  • Participants have 60 days to complete evaluations. After 60 days from November 14 or 15,2019 no credit will be available for this program.
  • Credits will be electronically transferred to the CPE Monitor System. No Statements of Credit will be issued by Northeastern University School of Pharmacy.
  • Program participants can earn up to 10 contact hours of continuing education credits including 2 contact hours in pharmacy law. 

Evaluation
All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs.

Statement of Disclosure
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Standards for Continuing Pharmacy Education 2009, Northeastern University School of Pharmacy requires that faculty members disclose any relationship (e.g., shareholder, recipient of research grant, consultant or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations. Such disclosure will be made available on the day of the program.

Accreditation Statement
Northeastern University Bouvé College of Health Sciences School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.